TarGLiO
Company/Start-up
Barcelona, Spain21 profile visits
About
TarGLiO is a therapeutic platform for the treatment of glioblastoma based on iron‑oxide magnetic nanoparticles. After intravenous administration, they are designed to reach and preferentially accumulate in the brain tumor, allowing their localization to be visualized by magnetic resonance imaging (MRI) and subsequently enabling the generation of localized hyperthermia through the application of an external alternating magnetic field.
Areas of activity
Life Science Domain
PharmaMedtechResearch
Pharma
Advanced therapy medicinal products (ATMPs)Oncology
Research
Academic spin-offs & start-upsNanomedicine & biomaterials
Representatives
CTO
TarGLiO